New study below [1] [2].
Some may recall that I have been going on about visceral fat for some years (this includes dangerous periprostatic fat.)
Visceral fat acts as though it were a gland in the endocrine system. It secretes hormones & these can help spur PCa aggressiveness.
Many studies link high BMI to poorer survival after diagnosis. There are a couple of things wrong with these studies, IMO. (i) the emphasis on obesity (as though overweight is OK) & (ii) the fact that BMI isn't useful for some body types - & does not always correlate with visceral fat. Some researchers make it clear that BMI is used as a surrogate because it is easy to calculate. Visceral fat can only be measured via a scan.
...
"The accumulation of fat in specific areas--such as visceral fat (deep in the abdomen, surrounding the organs) and thigh subcutaneous fat (just beneath the skin)--was associated with the risk of advanced and fatal prostate cancer."
""Interestingly, when we looked separately at men with a high BMI versus low BMI, we found that the association between visceral fat and advanced and fatal prostate cancer was stronger among men with a lower BMI."
...
I suppose that some men will further reduce fat intake, but visceral fat deposits are often due to triglycerides from high-carb diets.
-Patrick
[1] eurekalert.org/pub_releases...
In the first prospective study of directly measured body fat distribution and prostate cancer risk, investigators found that higher levels of abdominal and thigh fat are associated with an increased risk of aggressive prostate cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may lead to a better understanding of the relationship between obesity and prostate cancer and provide new insights for treatment.
Previous studies have shown that obesity is associated with an elevated risk of advanced prostate cancer and a poorer prognosis after diagnosis. Also, emerging evidence suggests that the specific distribution of fat in the body may be an important factor.
To provide high quality evidence, Barbra Dickerman, PhD, of the Harvard T.H. Chan School of Public Health, and her colleagues analyzed body fat distribution using the gold-standard measure of computed tomography imaging and assessed the risk of being diagnosed with, and dying from, prostate cancer among 1,832 Icelandic men who were followed for up to 13 years.
During the study, 172 men developed prostate cancer and 31 died from the disease. The accumulation of fat in specific areas--such as visceral fat (deep in the abdomen, surrounding the organs) and thigh subcutaneous fat (just beneath the skin)--was associated with the risk of advanced and fatal prostate cancer. High body mass index (BMI) and high waist circumference were also associated with higher risks of advanced and fatal prostate cancer.
"Interestingly, when we looked separately at men with a high BMI versus low BMI, we found that the association between visceral fat and advanced and fatal prostate cancer was stronger among men with a lower BMI. The precision of these estimates was limited in this subgroup analysis, but this is an intriguing signal for future research," Dickerman noted.
Additional studies are needed to investigate the role of fat distribution in the development and progression of prostate cancer and how changes in fat stores over time may affect patients' health. "Ultimately, identifying the patterns of fat distribution that are associated with the highest risk of clinically significant prostate cancer may help to elucidate the mechanisms linking obesity with aggressive disease and target men for intervention strategies," said Dickerman.
An accompanying editorial notes that lifestyle interventions--such as diet and exercise--that target fat loss may also reduce the risk of prostate cancer.
[2] onlinelibrary.wiley.com/doi...
Background
The World Cancer Research Fund classifies as “strong evidence” the link between obesity and the risk of advanced prostate cancer. In light of the different hormonal profiles associated with where adipose is stored, this study investigated the role of objectively measured body fat distribution and the risk of clinically relevant prostate cancer.
Methods
This was a prospective study of 1832 men in the Age, Gene/Environment Susceptibility–Reykjavik study. From 2002 to 2006, participants underwent baseline computed tomography imaging of fat deposition, bioelectric impedance analysis, and measurement of body mass index (BMI) and waist circumference. Men were followed through linkage with nationwide cancer registries for the incidence of total (n = 172), high‐grade (Gleason grade ≥8; n = 43), advanced (≥cT3b/N1/M1 at diagnosis or fatal prostate cancer over follow‐up; n = 41), and fatal prostate cancer (n = 31) through 2015. Cox regression was used to evaluate the association between adiposity measures and prostate cancer outcomes.
Results
Among all men, visceral fat (hazard ratio [HR], 1.31 per 1–standard deviation [SD] increase; 95% confidence interval [CI], 1.00‐1.72) and thigh subcutaneous fat (HR, 1.37 per 1‐SD increase; 95% CI, 1.00‐1.88) were associated with risk of advanced and fatal disease, respectively. Among men who were leaner based on BMI, visceral fat was associated with both advanced and fatal disease. BMI and waist circumference were associated with a higher risk of advanced and fatal disease. No adiposity measures were associated with total or high‐grade disease.
Conclusions
Specific fat depots as well as BMI and waist circumference were associated with the risk of aggressive prostate cancer, which may help to elucidate underlying mechanisms and target intervention strategies.